Atherosclerosis and Lipoproteins |
From the Wistar Institute and The Ludwig Institute for Cancer Research, Philadelphia, Pa; and the Department of Medicine and the Graduate Group in Immunology, University of Pennsylvania School of Medicine, Philadelphia.
Correspondence to Ellen Puré, PhD, The Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104. E-mail pure{at}wistar.org
Objective To identify early changes in vascular gene expression mediated by CD44 that promote atherosclerotic disease in apolipoprotein E (apoE)deficient (apoE/) mice.
Methods and Results We demonstrate that CD44 is upregulated and functionally activated in aortic arch in the atherogenic environment of apoE/ mice relative to wild-type (C57BL/6) controls. Moreover, CD44 activation even in apoE/ mice is selective to lesion-prone regions because neither the thoracic aorta from apoE/ mice nor the aortic arch of C57BL/6 mice exhibited upregulation of CD44 compared with thoracic aorta of CD57BL/6 mice. Consistent with these observations, gene expression profiling using cDNA microarrays and quantitative polymerase chain reaction revealed that
155 of 19 200 genes analyzed were differentially regulated in the aortic arch, but not in the thoracic aorta, in apoE/ CD44/ mice compared with apoE/ CD44+/+ mice. However, these genes were not regulated by CD44 in the context of a C57BL/6 background, illustrating the selective impact of CD44 on gene expression in a proatherogenic environment. The patterns of differential gene expression implicate CD44 in focal adhesion formation, extracellular matrix deposition, and angiogenesis, processes critical to atherosclerosis.
Conclusions CD44 is an early mediator of atherogenesis by virtue of its ability to regulate vascular gene expression in response to a proatherogenic environment.
We demonstrate that CD44 is selectively upregulated and functionally activated in lesion-prone aortic arch of apoE/ mice before lesion development. Furthermore, gene expression profiling revealed a selective impact of CD44 on vascular gene expression in response to a proatherogenic environment illustrating that CD44 is an early mediator of atherogenesis.
Key Words: CD44 apoE gene expression vascular hyaluronan atherosclerosis
This article has been cited by other articles:
![]() |
B. J. Bennett, S. S. Wang, X. Wang, X. Wu, and A. J. Lusis Genetic Regulation of Atherosclerotic Plaque Size and Morphology in the Innominate Artery of Hyperlipidemic Mice Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verschuren, J. de Vries-van der Weij, S. Zadelaar, R. Kleemann, and T. Kooistra LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms J. Lipid Res., February 1, 2009; 50(2): 301 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, E. Lee, A. M. Zukas, M. K. Middleton, M. Kinder, P. S. Acharya, J. A. Hall, D. J. Rader, and E. Pure CD44 Expressed on Both Bone Marrow-Derived and Non-Bone Marrow-Derived Cells Promotes Atherogenesis in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |